This site is intended for health professionals only

Gastroenterology

Certolizumab pegol for the treatment of Crohn’s disease
Certolizumab pegol for the treatment of Crohn’s disease
TNF-alpha-targeted therapy in inflammatory arthritides: a valuable option?
TNF-alpha-targeted therapy in inflammatory arthritides: a valuable option?
Mesalazine approved for ulcerative colitis
Mesalazine approved for ulcerative colitis
Early data released from Phase IIIb Cimzia trial
Early data released from Phase IIIb Cimzia trial
Watchdog approves Nexium for GERD
Watchdog approves Nexium for GERD
Sucampo files MAA for lubiprostone
Sucampo files MAA for lubiprostone
S-1 plus cisplatin holds hope for gastric cancer therapy
S-1 plus cisplatin holds hope for gastric cancer therapy
EU approves firms’ generic omeprazole
EU approves firms’ generic omeprazole
Once-daily mesalazine offers colitis hope
Once-daily mesalazine offers colitis hope
FDA grants provisional approval for copycat esomeprazole magnesium
FDA grants provisional approval for copycat esomeprazole magnesium
Xeloda approved for treatment of advanced bowel cancer
Xeloda approved for treatment of advanced bowel cancer
Little support for probiotic therapy in C diff colitis
Little support for probiotic therapy in C diff colitis
1 … 13 14 15 16 17 … 19


Most read

1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
2
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
3
Oral vitamin A could become an alternative to isotretinoin for acne
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Pharmacy workforce: matching staffing resource to service demand 



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe

Download Hospital Pharmacy Europe free app

Download our app from the Apple App Store Download our app from Google Play

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
×